Y-box protein-1 modulates circSPECC1 to promote glioma tumorigenesis via miR-615-5p/HIP1/AKT axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Y-box protein-1 modulates circSPECC1 to promote glioma tumorigenesis via miR-615-5p/HIP1/AKT axis

Published:2023-11-22 Issue:12 Volume:55 Page:1902-1912
ISSN:1672-9145
Container-title:Acta Biochimica et Biophysica Sinica
language:en
Short-container-title:ABBS

Author:

Lan Ping,Li Meihe,Wang Ying,Wang Jingwen,Li Luyao,Zhang Sha,Zhang Xuan,Ran Caihong,Zheng Jin,Gong Huilin

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine,Biochemistry,Biophysics,Molecular Biology

Link

https://engine.scichina.com/doi/pdf/ADD0EE6989FE4C2FBD93EC904617864F

Reference51 articles.

1. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology, 2019, 21: v1-v100.

2. Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet, 2018, 392: 432-446.

3. Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol, 2018, 51: 50-58.

4. Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics, 2017, 14: 284-297.

5. Saran F, Chinot OL, Henriksson R, Mason W, Wick W, Cloughesy T, Dhar S. Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy. Neuro Oncol, 2016, 18: 991-1001.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. m6A modification in non-coding RNAs: Mechanisms and potential therapeutic implications in fibrosis;Biomedicine & Pharmacotherapy;2024-10

2. UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma;Acta Biochimica et Biophysica Sinica;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3